Exam facts & prep options

Pharmacotherapy Specialty Certification Examination (BCPS)

The Board of Pharmacy Specialties' Pharmacotherapy specialty certification examination: a single continuous, computer-based exam of 150 items (125 scored, 25 unscored pretest) in 3 hours 45 minutes, covering three weighted domains (Patient Care Specialty Areas 36%, Therapeutics and Patient Management 36%, Professional Practice 28%). Passing requires a scaled score of at least 500 on a 200-800 scale set by criterion-referenced standard setting; passers earn the Board-Certified Pharmacotherapy Specialist (BCPS) designation. Delivered under continuous testing (scheduling within 90 days of application approval) primarily at Pearson test centers, with online/remote delivery only by case-by-case exception in the US, Australia, and Canada. First-time fee USD 600; discounted retake USD 300.

Official exam site
Start preparing1 prep option listed

Jump to prep options ↓

Questions150 items (125 scored, 25 unscored pretest items embedded in the test)
Testing time3 hours 45 minutes (covers exam introduction, tutorial, and the 150 items; no scheduled breaks — one optional 10-minute unscheduled break, deducted from the candidate's existing time)
ScoringCriterion-referenced passing standard set per specialty; minimum passing score is 500 on the 200-800 scale, and pass/fail decisions are based exclusively on the total score. Successful candidates receive no numerical score feedback
Exam feeUSD 600 first-time applicant fee; USD 300 discounted retake fee; after passing, a USD 125 Annual Certification Maintenance fee each year for years one through six plus a USD 400 recertification fee in year seven. Pearson-collected cancellation/reschedule fees: none at 30+ days out, USD 60 at 5-29 days, no change and full fee retained under 5 days. Complete applications are processed within 30 calendar days

Prep options

Study resources for BCPS

Independent prep

Courses and study resources

Exam overview

What to know before choosing your prep

Who runs it
BPS
Category
Pharmacist Specialty Certification
Current version
BCPS Examination Specifications effective September 2024 (eligibility/content outline for 2025 administrations and onward)
Where it applies
Global
Exam languages
English
Score scale
200-800 (500 = passing point)
Testing provider
Pearson (Pearson VUE, branded 'Pearson Professional Assessments (formerly Pearson VUE)'), BPS's exam delivery partner
Format
Computer-based, delivered primarily at Pearson test centers; no scheduled breaks (one optional 10-minute unscheduled break deducted from exam time); online/remote testing is not a standard option and is approved only case-by-case for eligible candidates in the United States, Australia, and Canada with advance BPS approval
Availability
Continuous testing: candidates may register throughout the year and take the exam at any point in their eligibility period; from the date of application approval the session may be scheduled any time within the following 90 calendar days; complete applications are processed within 30 calendar days
Results
Beginning January 2026, an immediate preliminary pass/fail score report is shown on screen at completion, with the official score report available in the candidate's MyBPS account within 45 calendar days of the test session
Remote testing
Varies by jurisdiction

Exam structure

One continuous computer-based exam of 150 items (125 scored, 25 pretest) across three weighted domains: 1. Patient Care Specialty Areas 36% (Primary Pharmacotherapy Specialty Areas 14%, Secondary 13%, Tertiary 9%), 2. Therapeutics and Patient Management 36% (Treatment Planning 10%, Therapeutic Implementation 13%, Treatment Outcomes and Monitoring 13%), 3. Professional Practice 28% (Quality of Care 13%, Evidence-Based Practice 7%, Practice Management 8%). Items are predominantly four-option multiple choice

Where rules vary

Open to pharmacists licensed/registered in the U.S. or another jurisdiction and delivered at Pearson test centers internationally; the certifying body is U.S.-based but the examination is not restricted to one country. BPS notes case-by-case remote approval limited to the United States, Australia, and Canada.

Eligibility

Graduation from an ACPE-accredited pharmacy program (or a non-U.S. program that qualifies the individual to practice in that jurisdiction); a current, active pharmacist license/registration in the U.S. or another jurisdiction; and, within the past 7 years, either at least 3 years of pharmacotherapy practice experience with at least 50% of time in the exam scope, or successful completion of a PGY1 pharmacy residency. A PDF/JPG of the current license must be uploaded with the application, with documentation submitted in English

Retake policy

Three total attempts (first attempt plus two retakes); a mandatory 90-calendar-day washout period between the last session and the scheduled retake; if a passing score is not achieved after the third attempt, the examinee must wait 12 months from the final attempt before submitting a new application with the $600 fee